This JAMA Internal Medicine Patient Page describes how glucagon-like peptide-1 (GLP-1) receptor agonists work and what behaviors to adopt while using them.
Recent Resources
Autistic patients
Ensuring accessibility helps reduce missed health care for autistic people. Health care delivery should be adapted in light of autism-related sensory profiles. Tailored accommodations should be implemented for each autistic patient’s unique communication profiles and preferences. Health care...
Over-the-Counter Progestin-Only Oral Contraceptives
Oral contraceptives are pills that prevent pregnancy. Most oral contraceptive pills contain 2 hormones—estrogen and progestin—that are naturally present in the bodies of individuals who are capable of becoming pregnant. Progestin-only oral contraceptive pills can be used by individuals who...
Oral Antiviral Medications for COVID-19
Twonewantiviralmedications, ritonavir-boostednirmatrelvir (Paxlovid,
ie, nirmatrelvir-ritonavir) and molnupiravir (Lagevrio), are currently
available in theUS underemergency useauthorization. These 2 drugs
areauthorized for treatmentofpatientswithmild tomoderateCOVID19 who are...
GLP1Agonists and SGLT2 Inhibitors Table
Based upon the following two meta-analyses:
1. Alexander JT, et al. The longer-term benefits and harms of glucagon-like peptide-1 receptor agonists: A Systematic review and meta-analysis. JGIM, 2021; 7(2): 415-43.
2. Alexander JT, et al. Longer-term benefits and risks of sodium-...
Action Collaborative on Countering the U.S. Opioid Epidemic May 21 Public Virtual Symposium
Not available.
Impact of Diabetes Medications on Cardiovascular Events and Mortality
No abstract available.
OSDH Health Advisory: Update to Criteria to Guide Evaluation and Laboratory Testing for COVID-19
No abstract available.
Sequences for putting on / taking off personal protective equipment
No abstract available.
- 1
- 2